推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33363733,021-34612310

chinasupport@letpub.com

登录 注册 新注册优惠

International Immunopharmacology

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 INT IMMUNOPHARM最新评论:请问楼主大大怎么看under review后要编辑邀请了几个审稿人呀 (2024-10-01)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


International Immunopharmacology期刊基本信息Hello,您是该期刊的第331766位访客


基本信息 登录收藏
期刊名字International ImmunopharmacologyInternational Immunopharmacology

INT IMMUNOPHARMACOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.5
103人评分
我要评分

声誉
8.0

影响力
6.8

速度
8.7

期刊ISSN1567-5769
微信扫码收藏此期刊
E-ISSN1878-1705
2023-2024最新影响因子
(数据来源于搜索引擎)
4.8 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:4.735
2023-2024自引率4.20%点击查看自引率趋势图
五年影响因子5
JCI期刊引文指标 1.24
h-index 98
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
8.401.1670.946
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q160 / 313
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Immunology and Allergy
Q261 / 233
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Immunology
Q272 / 236

期刊简介
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
期刊官方网站https://www.journals.elsevier.com/international-immunopharmacology
期刊投稿网址https://www.editorialmanager.com/INTIMP
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足International Immunopharmacology的语言要求,还能让International Immunopharmacology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被International Immunopharmacology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢(12篇)
提交文稿
是否OA开放访问No
通讯方式ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
出版商Elsevier
涉及的研究方向医学-免疫学
出版国家或地区NETHERLANDS
出版语言English
出版周期Monthly
出版年份2001
年文章数 1554点击查看年文章数趋势图
Gold OA文章占比14.48%
研究类文章占比:
文章 ÷(文章 + 综述)
91.76%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:IMMUNOLOGYSCIEQ251/181
学科:PHARMACOLOGY & PHARMACYSCIEQ150/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:IMMUNOLOGYSCIEQ132/181
学科:PHARMACOLOGY & PHARMACYSCIEQ152/354
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
IMMUNOLOGY
免疫学
4区4区2区
PHARMACOLOGY & PHARMACY
药学
2区3区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区1区
IMMUNOLOGY
免疫学
1区2区2区
PHARMACOLOGY & PHARMACY
药学
2区3区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
PHARMACOLOGY & PHARMACY
药学
2区3区2区
IMMUNOLOGY
免疫学
3区4区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769%5BISSN%5D
平均审稿速度网友分享经验:
平均2.7个月
来源Elsevier官网:
平均7.5周
平均录用比例网友分享经验:
约81.66%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在International Immunopharmacology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
在线出版周期来源Elsevier官网:
平均2.7周
期刊常用信息链接
同领域相关期刊 International Immunopharmacology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 International Immunopharmacology中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
International Immunopharmacology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE REVIEWS IMMUNOLOGY35193.40
    NATURE IMMUNOLOGY34440.00
    Annual Review of Immunology27957.20
    Immunity35549.40
    Cellular & Molecular Immunology6431.20
    TRENDS IN IMMUNOLOGY20925.10
    JOURNAL OF EXPERIMENTAL MEDICINE41126.60
    AUTOIMMUNITY REVIEWS10324.70
    BRAIN BEHAVIOR AND IMMUNITY12729.60
    JOURNAL OF AUTOIMMUNITY10127.90
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE659418
    BIOMATERIALS554964
    BIOMEDICINE & PHARMACOTHERAPY532919
    Frontiers in Pharmacology500941
    Journal of Materials Chemistry B492507
    Frontiers in Immunology476769
    COMPUTERS IN BIOLOGY AND MEDICINE453264
    JOURNAL OF ETHNOPHARMACOLOGY451747
    COLLOIDS AND SURFACES B-BIOINTERFACES430758
    Frontiers in Oncology424788
  •  

    International Immunopharmacology International Immunopharmacology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Subthreshold splenic nerve stimulation prevents myocardial Ischemia-Reperfusion injury via neuroimmunomodulation of proinflammatory factor levels

    Author: Jin, Xiaoxing; Wang, Xiaofei; Sun, Ji; Tan, Wuping; Zhang, Guocheng; Han, Jiapeng; Xie, Mengjie; Zhou, Liping; Yu, Zhiyao; Xu, Tianyou; Wang, Changyi; Wang, Yueyi; Zhou, Xiaoya; Jiang, Hong
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109522
        PubMed      DOI
    2.PIM1 attenuates renal ischemia-reperfusion injury by inhibiting ASK1-JNK/P38

    Author: Luo, Yanwen; Zhu, Jiefu; Zhao, Fan; Shi, Lang; Li, Yuzhen; Wu, Xiongfei
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109563
        PubMed      DOI
    3.Association between serum levels of 12 different cytokines and short-term efficacy of anti-PD-1 monoclonal antibody combined with chemotherapy in advanced gastric cancer

    Author: Qi, Qiufeng; Peng, Yun; Zhu, Ming; Zhang, Yaping; Bao, Yanqing; Zhang, Xiaobin; Zhang, Jianqing; Liu, Yongping
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109553
        PubMed      DOI
    4.Intralesional Bacillus Calmette-Gu?erin injections and hypo-fractionated radiation synergistically induce systemic antitumor immune responses

    Author: Yang, Hanshan; Hu, Yuru; Kong, Deyi; Chen, Ping; Yang, Linglin
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109542
        PubMed      DOI
    5.PLZF promotes the development of asthma tolerance via affecting memory phenotypes of immune cells

    Author: Li, Na; Shi, Tianyun; Zhang, Meng; He, Yanchao; Feng, Jingjing; Mei, Zhoufang; Su, Xiao; Jie, Zhijun
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109559
        PubMed      DOI
    6.Effect of inactivated COVID-19 vaccination on pregnancy outcomes following frozen-thawed embryo transfer: A retrospective cohort study

    Author: Huang, Jialyu; Liu, Yiqi; Zeng, Han; Tian, Lifeng; Hu, Yina; He, Jinxia; Nie, Ling; Li, You; Fang, Zheng; Deng, Weiping; Chen, Mengyi; Zhao, Xia; Ouyang, Dongxiang; Fu, Yuqing; Lin, Jiaying; Xia, Leizhen; Wu, Qiongfang
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109552
        PubMed      DOI
    7.KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-KB signaling

    Author: Yuan, Hongyi; Wei, Shufei; Ren, Zongtao; Li, Feng; Liu, Bin; Liu, Rui; Zhang, Xiaoyu
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109202
        PubMed      DOI
    8.Molecular hydrogen attenuates sepsis-induced cognitive dysfunction through regulation of tau phosphorylation

    Author: Qi, Bo; Song, Yu; Chen, Chen; Zhao, Lina; Ma, Wanjie; Meng, Shuqi; Zhuang, Xiaoli; Lin, Huayi; Liang, Jing; Cui, Yan; Xie, Keliang
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109603
        PubMed      DOI
    9.A ROS/GAS5/SIRT1 reinforcing feedback promotes oxidative stress-induced adipogenesis in bone marrow-derived mesenchymal stem cells during osteoporosis

    Author: Lin, Tao; Zhang, Zheng; Wu, Jinhui; Jiang, Heng; Wang, Ce; Ma, Jun; Yin, Yan; Wang, Suchun; Gao, Rui; Zhou, Xuhui
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109560
        PubMed      DOI
    10.PPAR gamma/RAD21 alleviates peripheral secondary brain injury in rat cerebral hemorrhage model through promoting M2 polarization of microglial cells

    Author: Jiao, Yu; Ren, Siying; Wang, Likun; Wu, Guofeng
    Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109572
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity069.90
    Living Reviews in Relativity7569.90
    Advanced Composites and Hybrid Materials026.00
    Kidney International Supplements2026.70
    Kidney International Supplements2426.70
    Wiley Interdisciplinary Reviews-Computational Molecular Science6228.90
    Military Medical Research038.40
    NUCLEIC ACIDS RESEARCH45227.10
    Environmental Chemistry Letters5032.00
    Journal of the National Comprehensive Cancer Network8820.20
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共1413


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室